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Abstract
Background: Toad secretions are a source of molecules with potential biotechnological application on a wide
spectrum of diseases. Toads from the Rhinella family have two kinds of poisonous glands, namely granular and
mucous glands. Rhinella schneideri toads produce granular secretions that comprise a great number of molecules,
including serine proteases inhibitors. Serine proteases, such as trypsin, chymotrypsin and elastase, are enzymes that
have a serine amino acid into its catalytic site and can be found in a large number of vertebrate species and
pathogenic microorganisms. Therefore, the present work aims to purify a serine protease inhibitor from Rhinella
schneideri granular secretions.
Findings: This study presents the protocol used to purify a serine protease inhibitor from the Rhinella schneideri
poison. The granular secretion was submitted to dialysis in order to separate the low molecular weight compounds,
which were submitted to a reversed phase-fast protein liquid chromatography fractionation step in a C2C18
column. The major fractions were tested over trypsin, chymotrypsin and elastase through colorimetric assay. The
inhibition tests were performed with the enzyme in absence (positive control) and presence of fractions, denatured
enzyme (negative control) and the respective chromogenic substrate. Rs20 was the compound with the major
inhibitory activity over chymotrypsin, inducing a delay in the formation of the chromogenic enzymatic product. The
structure characterization of Rs20 was performed by high resolution electronspray ionization-mass spectrometry
(HRESI-MS) and gas chromatography coupled with mass spectrometry (GC-MS). HRESI showed an intense signal
suggesting the presence of bufadienolide with less than 10 ppm error. In addition, it was observed a low intense
signal at m/z 399 that could be lithocholic acid, a biosynthetic precursor of bufadienolide. Finally, GC-MS analysis
applying NIST library identification reinforced this hypothesis.
Conclusions: The current study have isolated and partially characterized the function and structure of the first
bufadienolide with inhibitory action over chymotrypsin.
Keywords: Bufadienolide, Rhinella schneideri, Serine protease inhibitor
Background
Rhinella schneideri toads, that are widespread through-
out the South American territory, have two types of
glands: granular and mucous. Mucous glands can be
found along the entire animal body and their secretion
aid toad survival in inhospitable habitats, since they
assist in skin hydration and gas exchange [1].
The secretion of granular glands, or parotoid glands, is
responsible for the toad passive defense against preda-
tors [2]. This poison is composed of biogenic amines,
steroids, alkaloids, peptides and proteins [3]. Whereas
steroids are responsible for accelerating the heart rate of
affected animals, inducing apoptosis and hallucinogenic
effects, the peptides and proteins are believed to im-
prove toad defense against microorganisms [4]. Most
studies focus on this kind of poison due to its com-
position and diversity of effects induced by their
components [5].
Serine proteases enzymes present an amino acid serine
on its catalytic site. The serine interacts with a carbonyl
group from the substrate, facilitating an acyl group
transfer that results in a peptide cleavage [6]. Such en-
zymes are related to several functions that are intrinsic
to homeostasis [7–10]. It is expected that animals that
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lived in such an inhospitable habitat have created their
own arsenal of serine protease inhibitors along the
course of time, which is named evolutionary arms race
[11]. Previous studies with Anurans have demonstrated




Adult specimens (n = 5) of Rhinella schneideri from the
animal facility of the University of São Paulo in Ribeirão
Preto, were used for poison extraction. It was performed
by mechanical pressure on the parotoid glands. The se-
cretion (pool of five extractions) was dried and stored
at–20 °C. A poison sample can be found at the venom
bank of the Center for the Study of Venoms and
Venomous Animals (CEVAP/UNESP). The poison sus-
pension (500 mg in 20 mL of water) was dialyzed on a
6–8 kDa pore membrane against deionized water. The
dialysis water containing the molecules that permeate
the membrane (molecular weight < 8 kDa) was frozen,
lyophilized and stored at–20 °C.
Purification of a serine protease inhibitor
The sample (3 mg) obtained from dialysis water was dis-
persed in 40 μL of acetonitrile and then 0.1 % trifluora-
cetic acid (TFA) solution (360 μL) and water (600 μL)
were added to the solution completing 1 mL. The solu-
tion was submitted to reversed-phase fast protein liquid
chromatography (RP-FPLC) using a C2C18 column
(μRPC C2/C18 ST 4.6/100, Amersham Biosciences,
Sweden) equilibrated with 0.1 % TFA (solution A), at
flow rate of 1 mL/min. Fractions elution was monitored
at 280 nm in ÄktaBasic UPC system (GE, Sweden).
High resolution electronspray ionization-mass
spectrometry (HRESI-MS)
The sample called Rs20 was analyzed in a high reso-
lution eletronspray mass spectrometer (HRESI-MS)
(Bruker Daltonic, USA) and was direct infused in the
ESI source though a syringe pump (Kd Scientific, USA).
Nitrogen was used as dry gas at 180 °C (under 4 L/min
flow) and as nebulization gas (pressure of 0.4 Bar). The
capillary voltage was set up to 3500 volts. Sodium tri-
fluoracetate was applied as internal calibration before
the data.
Gas chromatography coupled with mass spectrometry
analyzer (GC/MS)
Rs20 was also analyzed in GC/MS equipment (Shimadzu
QP2010, Japan). One microliter of sample solutions was
injected at 220 °C in a HP-5MS column (30 m ×
0.25 mm × 0.25 μm; Agilent Technologies). The analysis
was performed with two minute sample time in splitless
injection mode, column flow of 1.28 mL/min, linear
velocity of 44.1 cm/sec, and scan between m/z 40.00
and m/z 500.00. The oven temperature started with
220 °C for six minutes, increasing to 8 °C min−1
until 280 °C, this temperature was maintained for
20 minutes, then increased to 15 °C min−1 until 310 °C
and then kept for 40 minutes. Lithocholic acid structure
was proposed by comparison with NIST library.
Serine protease inhibitory assay
The major fractions Rs1, Rs4, Rs7, Rs9, Rs10, Rs15,
Rs16, Rs17, Rs20 and Rs22 from the RP-FPLC fraction-
ation were submitted to inhibitory activity assay with the
three serine proteases, porcine trypsin, chymotrypsin
and porcine elastase. Inhibitory activity assay was per-
formed by mixing the fractions (1 mg/mL, 100 μL) with
each enzyme (1 mg/mL, 50 μL) and PBS buffer (50 μL)
and incubating for 15 minutes at room temperature. En-
zyme activity was determined by adding the correspondent
chromogenic substrate (1 mg/mL, 100 μL). The substrates
used were N-Tosylglycyl-L-prolyl-L-lysine 4-nitroanilide
acetate salt, N-Succinyl-Ala-Ala-Pro-Phe-4-nitroanilide
and N-Succinyl-Ala-Ala-Ala-p-nitroanilide for porcine
trypsin, chymotrypsin and elastase, respectively. The
formation of p-nitroanilide was monitored at 405 nm,
every two minutes, for 60 minutes. Positive (enzyme,
buffer and corresponding substrate) and negative (fraction,
denatured enzyme, buffer and corresponding substrate)
controls, and Rs20 enzymatic action (fraction, buffer and
substrate) were performed. The poison enzymatic inhibi-
tory assay was also performed by mixing poison solution
(10 mg/mL, 100 μL) with the enzymes and PBS buffer, as
described for the assays with fractions. Assays were per-
formed only once in triplicate.
Statistical analysis
The results were expressed as the mean ± SEM. Statistical
comparisons among the groups were carried out using
ANOVA followed by the student’s t-test. Data were statisti-
cally significant when p < 0.05. All data analyses were done
using Prism™ v.5 (GraphPad Inc., USA).
Conclusions
Purification of serine proteases inhibitor
The purification by RP-FPLC resulted in 25 fractions
(Fig. 1a), Rs1 to Rs25. Each fraction was frozen and
lyophilized.
Mass spectrometry analysis
The fraction Rs20 showed the highest serine protease
inhibition over chymotrypsin and was submitted to ESI-
TOF spectrometer. The HRESI-MS (Fig. 1b) shows a
relevant ion with m/z of 425.2258. This ion matches
with telocinobufagin molecular weight with a sodium
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adduct [16]. The analysis was performed in high-
resolution equipment and the error (9.6 ppm) was deter-
mined. This result suggests telocinobufagin as a possible
inhibitor. Another signal was observed in ESI analysis,
but at low intensity (m/z 399) which can be related to
the lithocholic acid (Fig. 1b inset), a biosynthetic precur-
sor of telocinobufagin. At GC-MS analysis (Fig. 1c, d
and e), telocinobufagin was not observed probably by
the low volatilization of its structure. In the other hand,
one signal was observed at 16.4 minutes (Fig. 1c) which
can be related to lithocholic acid. As expected, the mo-
lecular ion was not observed, only the water elimination
fragment (Fig. 1d). Comparison with the data in NIST-
08 spectrum library showed similar behavior (80 % of
similarity), suggesting the presence of the lithocholic
acid (Fig. 1e).
Inhibitory assay
Major fractions obtained from the RP-FPLC were tested
over the activity of three serine proteases (data not shown).
Rs20 showed significant inhibitory activity (p < 0.0001) over
chymotrypsin (Fig. 2a). Conversely, it did not show inhib-
ition over elastase (Fig. 2b) or trypsin (Fig. 2c). The poison
was able to inhibit both trypsin and chymotrypsin, with dif-
ferent potencies (Additional file 1). Assays were performed
only once in triplicate.
In this study, we isolated a poison component (Rs20)
with inhibitory activity over chymotrypsin. The poison
should have more than one serine protease inhibitor,
since it was able to delay the p-nitroanilide formation by
trypsin and chymotrypsin while Rs20 has shown a sig-
nificant inhibition only over chymotrypsin. Protease
inhibitors can be of protein or non-protein nature. The
protein inhibitors include baserpins, Kunitz inhibitors,
BSTI and others [13–19].
Triterpenes, phenolic compounds and alkaloids are
among non-protein molecules that may be found in
amphibian secretions, including toads from Rhinella
family. Daly et al. [20] listed more than 800 hundred al-




















































Fig. 1 RP-FPLC profile and structural characterization of Rs20 by HRESI-MS and GC/MS. a. RP-FPLC on a C2C18 column previously equilibrated with
solution A (TFA 0.1 %, V/V). The fractions were eluted with a concentration gradient of solution B (acetonitrile 80 % in TFA 0.1 %, V/V) until it reaches
100 % of solution B (dashed line). Flow rate: 1 mL/minute. b. ESI-microTOF mass spectrum of Rs20. The spectrum indicates the ion masses obtained
through positive mode. c. Gas chromatography profile. The spectrum is shown in total ion chromatogram (TIC) × time (minute). d. GC/MS mass
spectrum of Rs20. e. GC/MS mass spectrum of lithocholic acid
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occurrence may be explained by a bioaccumulation
process originated in the food chain: plants are able to
synthesize these kind of compounds through secondary
metabolism, they are eaten by insects that are preyed by
amphibians [21].
The purification strategy started with the poison dialy-
sis in a 6–8 kDa membrane, followed by RP-FPLC of the
sample containing low molecular weight compounds
(Fig. 1a). This protocol was able to successfully fraction-
ate the poison in 25 fractions (Rs1 to Rs22) with a high-
resolution profile.
Rs20 showed the greatest inhibitory activity over
chymotrypsin (Fig. 2b) and was chosen for structural
characterization through electrospray ionization and gas
chromatography coupled with a mass spectrometry
analyzer. The HRESI-MS spectrum (Fig. 1b) suggested
that Rs20 is a bufadienolide, probably the telocinobufa-
gin structure (Fig. 1b inset) [16]. The major ion m/z
425.2258 corresponds to the telocinobufagin (molecular
formula: C24H34O5) with a sodium adduct [M +Na]
+,
showing an error of 9.6 ppm [22]. Another minor ion
was observed in HRESI-MS analysis suggesting the
presence of the lithocholic acid (Fig. 1b inset). Fi-
nally, GC-MS analysis (Fig. 1c, d and e) supported
by NIST-08 spectrum library suggested the presence
of the lithocholic acid a biosynthetic precursor of
telocinobufagin.
Several biological actions have been reported for telo-
cinobufagin, such as antiproliferative activity towards
human cancer cells, antileishmanial activity and even
immunomodulatory activity [23–25]. This work showed
that this bufadienolide is also able to inhibit selectively
chymotrypsin (Fig. 2a), which is a new functional feature
of it. It would be expected that Rs20 would be able to in-
hibit trypsin activity, once they share almost the same
structure, with difference of two amino acids at their
catalytic site. Trypsin presents arginine at the 117th pos-
ition and valine at the 118th position, while chymotryp-
sin presents a phenylalanine at 114th position and serine
at 115th position [26, 27]. Conversely, it did not inhibit
trypsin (Fig. 2b) or elastase (Fig. 2c). Probably, the slight
changes at the catalytic site of chymotrypsin increases
the affinity between the bufadienolide and the enzyme.
In conclusion, this study have isolated and partially
characterized the function and structure of the first
bufadienolide with inhibitory action over chymotrypsin,
isolated from Rhinella schneideri poison.
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Fig. 2 Inhibition assays. a. Enzyme inhibition assay of Rs20 over trypsin.
b. Enzyme inhibition assay of Rs20 over chymotrypsin. c. Enzyme
inhibition assay of Rs20 over elastase. In the enzyme inhibition assays,
indicates positive control (enzyme, PBS buffer and substrate);
indicates assay performed in the presence of Rs20 (enzyme, Rs20,
PBS buffer and substrate); indicates negative control (denatured
enzyme, PBS buffer and substrate); and indicates the enzymatic
action of Rs20 (Rs20, buffer and substrate). The points represent the
means ± SEM of one experiment performed in triplicate. ** p < 0.01;
*** p < 0.001 and **** p < 0.0001 compared to the positive control
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